Patent · US Active

Amino-substituted imidazopyridazines

US9643974B2 · kind B2 · utility

0Cited by

3References

9Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Knut Eis · Berlin, DE
Florian Puehler · Wellesley, US
Ludwig Zorn · Berlin, DE
Volker Schulze · Hohen Neuendorf, DE
Detlev Sülzle · Berlin, DE
Philip Lienau · Berlin, DE
Andrea Hägebarth · Berlin, DE
Kirstin Petersen · Berlin, DE
Ulf Bömer · Glienicke, DE

Key dates

Filing date	Dec 10, 2012
Grant date	May 9, 2017
Priority date	—
Expiry date	Dec 10, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to amino-substituted imidazopyndazine compounds of general formula (I): in which A, R1, R2, R3, R4 and n are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.